108 related articles for article (PubMed ID: 31593307)
1. Unexpected high-risk pathologic features following thyroidectomy in the chinese immigrant population.
Badhey AK; Moshier E; Jategaonkar A; Wong A; Echanique K; Chai RL
Laryngoscope; 2020 Jul; 130(7):1844-1849. PubMed ID: 31593307
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
3. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD
J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine.
Rosario PW; Mourão G; Calsolari MR
J Endocrinol Invest; 2019 Jun; 42(6):687-692. PubMed ID: 30353424
[TBL] [Abstract][Full Text] [Related]
5. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
6. Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor.
Castagna MG; Forleo R; Maino F; Fralassi N; Barbato F; Palmitesta P; Pilli T; Capezzone M; Brilli L; Ciuoli C; Cantara S; Formichi C; Pacini F
J Endocrinol Invest; 2018 Sep; 41(9):1029-1035. PubMed ID: 29470826
[TBL] [Abstract][Full Text] [Related]
7. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
[TBL] [Abstract][Full Text] [Related]
8. The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients.
Almeida MFO; Couto JS; Ticly ALT; Guardia VC; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RDP
Arch Endocrinol Metab; 2020; 64(3):251-256. PubMed ID: 32555991
[TBL] [Abstract][Full Text] [Related]
9. Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data.
Zhang HS; Lee EK; Jung YS; Nam BH; Jung KW; Kong HJ; Won YJ; Park B
Surgery; 2019 Mar; 165(3):629-636. PubMed ID: 30342774
[TBL] [Abstract][Full Text] [Related]
10. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
11. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes of robotic thyroidectomy vs. conventional open thyroidectomy for papillary thyroid carcinoma.
Cho JN; Park WS; Min SY; Han SA; Song JY
World J Surg Oncol; 2016 Jul; 14(1):181. PubMed ID: 27393007
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
14. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
15. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
17. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
18. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
19. Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
Su HK; Wenig BM; Haser GC; Rowe ME; Asa SL; Baloch Z; Du E; Faquin WC; Fellegara G; Giordano T; Ghossein R; LiVolsi VA; Lloyd R; Mete O; Ozbek U; Rosai J; Suster S; Thompson LD; Turk AT; Urken ML
Thyroid; 2016 Apr; 26(4):512-7. PubMed ID: 26953223
[TBL] [Abstract][Full Text] [Related]
20. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
